User profiles for Riccardo Magistroni
Riccardo MagistroniAssistant Professor Verified email at unimore.it Cited by 5622 |
Unified criteria for ultrasonographic diagnosis of ADPKD
Individuals who are at risk for autosomal dominant polycystic kidney disease are often screened
by ultrasound using diagnostic criteria derived from individuals with mutations in PKD1. …
by ultrasound using diagnostic criteria derived from individuals with mutations in PKD1. …
Genome-wide association study identifies susceptibility loci for IgA nephropathy
We carried out a genome-wide association study of IgA nephropathy, a major cause of kidney
failure worldwide. We studied 1,194 cases and 902 controls of Chinese Han ancestry, with …
failure worldwide. We studied 1,194 cases and 902 controls of Chinese Han ancestry, with …
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
…, R Coppo, M Salvadori, P Ravani, R Magistroni… - Nature …, 2014 - nature.com
We performed a genome-wide association study (GWAS) of IgA nephropathy (IgAN), the most
common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of …
common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of …
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy
…, S Granata, G Zaza, F Londrino, R Magistroni… - Nature …, 2023 - nature.com
IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular
deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-…
deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-…
[HTML][HTML] New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
R Magistroni, VD D'Agati, GB Appel, K Kiryluk - Kidney international, 2015 - Elsevier
Recent years have brought notable progress in the field of IgA nephropathy. Here, we
highlight important new directions and latest developments, including successful discovery of …
highlight important new directions and latest developments, including successful discovery of …
[HTML][HTML] The MEST score provides earlier risk prediction in lgA nephropathy
…, A Wiecek, M Ots-Rosenberg, R Magistroni… - Kidney international, 2016 - Elsevier
The Oxford Classification of IgA nephropathy (IgAN) includes the following four histologic
components: mesangial (M) and endocapillary (E) hypercellularity, segmental sclerosis (S) and …
components: mesangial (M) and endocapillary (E) hypercellularity, segmental sclerosis (S) and …
Rituximab or cyclophosphamide in the treatment of membranous nephropathy: the RI-CYCLO randomized trial
…, C Marcantoni, P Passerini, R Magistroni… - Journal of the …, 2021 - journals.lww.com
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a more …
membranous nephropathy. Compared with this regimen, rituximab therapy might have a more …
[HTML][HTML] Hypokalemia in patients with COVID-19
…, R Perrone, G Mori, E Ascione, R Magistroni… - Clinical and …, 2021 - Springer
Background Patients with COVID-19 experience multiple clinical conditions that may cause
electrolyte imbalances. Hypokalemia is a concerning electrolyte disorder closely associated …
electrolyte imbalances. Hypokalemia is a concerning electrolyte disorder closely associated …
Covid‐19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine
…, F Facchini, F Damiano, R Magistroni… - American Journal of …, 2020 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19) pneumonia has been poorly reported in solid organ
transplanted patients; prognosis is uncertain and best management unclear. We describe …
transplanted patients; prognosis is uncertain and best management unclear. We describe …
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy
Results IgG 4 was the most common isotype for all antibodies; IgG 1 and IgG 3 were nearly
negligible. IgG 4 levels were positive in a significant proportion of MN patients (AR, 34%; …
negligible. IgG 4 levels were positive in a significant proportion of MN patients (AR, 34%; …